Review on lipegfilgrastim

Authors:

Abstract
Review on lipegfilgrastim Maja Gasparic, Sophie Leyman Teva Pharmaceuticals Europe BV, European Headquarters, Amsterdam, the NetherlandsHaving read the original Hoggatt et al article1 and the corrigendum published online on August 27, 2015,2 we do not consider the description of lipegfilgrastim to be entirely accurate, and we would therefore like to clarify what lipegfilgrastim actually is.The description of lipegfilgrastim used in the original article was a â

This publication has 2 references indexed in Scilit: